RxDoctor Payments Data

Jeffrey Radack

Foot & Ankle Surgery · McKinney, TXNPI 1679667430

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.7%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Treace Medical Concepts, Inc. accounts for 66.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $2,600 and has fallen 87.7% since, to $320 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in TX, where the typical reported total is $3,901.

$3,818in general payments, 2019–2025

Across 65 payments — averaging $58.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$3K
  • Paratek Pharmaceuticals, Inc.$298
  • Nevro Corp.$245
  • Stryker$153
  • Amgen$151
  • Johnson & Johnson$97
  • plus $329 from 12 others

What the payments were for

  • Travel & lodging$1,93451%
  • Food & beverage$1,78847%
  • Gifts$952%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,818 in reported general payments places this provider in the 45th percentile of 684 foot & ankle surgery providers in Texas.

See all foot & ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$57,950
Medicare patients
235
Services billed
748

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin22$753
Ciclopirox13$330
Gabapentin25$207
Doxycycline Hyclate22$176
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$107
SsdSilver Sulfadiazine14$106
Cephalexin19$103
Methylprednisolone14$80
Clindamycin Hcl14$80

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in McKinney

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →